On 12 Nov 2026 Lennar closed at $83.58, -16.9% this year; market cap $19.87bn, P/E 15.2.
Consumer Discretionary · Homebuilding · NYSE · United States
Lennar Corporation, together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand in the United States. It operates through Homebuilding East, Homebuilding Central, Homebuilding South Central, Homebuilding West, Financial Services, Multifamily, and Lennar Other segments. The company's homebuilding operations include the construction and sale of single-family attached and detached homes, as well as the purchase, development, and sale of residential land; and development, construction, and management of multifamily rental properties. It also offers residential mortgage financing, title insurance, and closing services for home buyers and others, as well as originating and selling securitization commercial mortgage loans. In addition, the company is involved in fund investment activities. It primarily serves first-time, move-up, active adult, and luxury homebuyers. The company was founded in 1954 and is based in Miami, Florida.
| Market cap | $19.87bn |
| P/E (trailing) | 15.2 |
| EPS (TTM) | $5.52 |
| Beta | 1.38 |
| Dividend | $2.00 |
| Dividend yield | 2.39% |
| Ex-dividend date | 7 Oct 2026 |
| Latest report | 16 Sep 2026 |
| Next earnings | 15 Dec 2026 |
| YTD | -16.9% |
| 1Y | -31.2% |
| 3Y | -9.4% |
| 5Y | -2.8% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $34.19bn | $2.08bn | $28.18m |
| 2024 | $35.44bn | $3.93bn | $2.23bn |
| 2023 | $34.23bn | $3.94bn | $5.08bn |
| 2022 | $33.67bn | $4.61bn | $3.21bn |
| 2021 | $27.13bn | $4.43bn | $2.47bn |
We publish no single base value for Lennar. Our valuation methods put it between $25.68 and $26.41 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.